SCHEMBL22493475

SCHEMBL22493475

CC(C)(C)NCCc1cccc(Oc2ccccc2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.36
KCNH2 Q12809 2/20 0.36
CYP2D6 P10635 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
F2 P00734 2/20 0.35
F10 P00742 2/20 0.35
PAX8 Q06710 1/20 0.35
PRSS1 P07477 1/20 0.35
PRSS2 P07478 1/20 0.35
PRSS3 P35030 1/20 0.35
ST14 Q9Y5Y6 1/20 0.35
NUDT1 P36639 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAP4K4 O95819 1/20 0.34
KDM4E B2RXH2 1/20 0.34
LOXL2 Q9Y4K0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22481324 0.79 MAPK8 (0.46) KCNH2KDM4EALDH1A1
SCHEMBL22480852 0.78 TRPV3 (0.38) KCNH2CYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL22493897 0.78 TRPV3 (0.38) KCNH2
SCHEMBL10841713 0.75 F2 (0.44) OPRM1KCNH2CYP1A2CYP2C9CYP2C19
SCHEMBL9198043 0.75 KCNH2 (0.44) KCNH2CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL17886911 0.73 SMN1; SMN2 (0.46) OPRM1KCNH2SMN1; SMN2ALDH1A1
SCHEMBL10653082 0.73 KDM4E (0.44) OPRM1MAPTSMN1; SMN2L3MBTL1KDM4E
SCHEMBL14282017 0.73 KCNH2 (0.50) OPRM1KCNH2CYP1A2MAPTCYP2C9
SCHEMBL6856754 0.72 KCNH2 (0.44) KCNH2CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL22493399 0.72 CYP3A4 (0.36) KCNH2CYP2D6MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137506-A1 COMPOSITIONS AND METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS CURASEN THERAPEUTICS, INC. (US) 2024-06-27 WO disclosed
WO-2020198466-A9 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
WO-2020198466-A1 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed